Drawing for Serial No. 87594262

USPTO serial 87594262

Serial No. 87594262

Reviewed by CopyMark Law Group

Reg. 5573277Status 702Registered
Filing date
Status date
Registration date
Oct 2, 2018
Examiner
GALBO, AMANDA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with Serial No. 87594262?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia Johnson Walden

Cynthia Johnson Walden FISH & RICHARDSON P.C.PO BOX 1022MINNEAPOLIS, MN 55440-1022United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable audio materials, audio-visual materials, video materials, written materials, and visual materials providing pharmaceutical, medical, healthcare, and life sciences information and analysis; Downloadable electronic publications in the nature of brochures, reports and white papers in the pharmaceutical, medical, healthcare and life sciences fields; Computer software, mobile applications and downloadable instructional manuals for use in data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Computer software, mobile applications and instruction manuals sold as a unit therewith, for healthcare management, namely, patient, prescriber, payor and employee management; Electronic database recorded on computer media containing pharmaceutical, medical, healthcare, and life sciences information; Computer software for collecting, managing, and analyzing clinical trial data and information in the pharmaceutical, medical, healthcare and life sciences fields; Computer hardware and software for healthcare management and electronic health record management; Computer software for collecting, managing, and analyzing data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fieldsACTIVENov 7, 2017
035Market analysis and research services; Business market consulting; Marketing consulting; Business consulting and information services; Business consulting services and business management consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Business process outsourcing services in the pharmaceutical, medical, healthcare, and life sciences fields; Providing a web-based online portal that provides customer access to pharmaceutical, medical, healthcare, and life sciences information; Public policy research services; Computerized database management and data processing services in the pharmaceutical, medical, healthcare, and life sciences fields; Independent sales representatives in the pharmaceutical, medical, healthcare, and life sciences fields; Business consultation and management regarding marketing activities, launching of new products and services, and sales; Personnel recruitment and placement; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; Providing independent review of clinical trials for business purposes; Maintaining a registry of patients; Business consulting and business management consultation services related to healthcare management and electronic health records management; Business management consulting and advisory services in pharmaceutical, medical, healthcare, and life sciences fields; Advertising, marketing and promotional services in the pharmaceutical, medical, healthcare, and life sciences fields; Business management services, namely, quality management services for establishing business quality policies for patient-care programs; Recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of drugs, biologics and devices; Business consulting in the fields of healthcare managementACTIVENov 7, 2017
041Education and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the pharmaceutical, medical, healthcare, and life sciences fields; Educational and training services, namely, conducting conferences to train physicians and other medical providers on conducting clinical trials; Education and training services, namely, providing non-downloadable webinars, webcasts and digital content in the form of podcasts in the pharmaceutical, medical, healthcare, and life sciences fields; Non-downloadable online publications in the nature of brochures, reports, or white papers in the pharmaceutical, medical, healthcare, and life sciences fields; Medical evaluation and education services, namely, education in the form of individual training and classes for training of patients, physicians and other healthcare providers on disease and treatment managementACTIVENov 7, 2017
042Providing online, non-downloadable software providing pharmaceutical, medical, healthcare, and life sciences information and analysis; Software as a service (SAAS) services featuring software providing, collecting, analyzing pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, providing on-line, non-downloadable computer software used for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; Research related to pharmaceutical, medical, healthcare, and life sciences information; computer services, namely, designing, developing and maintaining application software in the field of pharmaceutical, medical, healthcare, and life sciences information; Computer software development for others; Clinical research, clinical testing, and laboratory testing services in the pharmaceutical, medical, healthcare, and life sciences fields; Product development consultation in the pharmaceutical, medical, healthcare, medical and life sciences fields; Conducting clinical trials for others; Providing temporary use of on-line non-downloadable software for use in healthcare and electronic health record management; Information technology consulting services; Computer software consultation services in the pharmaceutical, medical, healthcare, and life sciences fields; Scientific research in the pharmaceutical, medical, healthcare, and life sciences fields; Computer services, namely, creating computer network-based indexes and databases of information; providing electronic data capture and data management systems, namely, providing temporary use of online, non-downloadable software for collection and management of healthcare and life sciences data; Providing temporary use of online, non-downloadable computer software for collecting, managing, and analyzing clinical trial data; Providing an on-line interactive database featuring scientific research information in the pharmaceutical, medical, healthcare, and life sciences fields; Providing information relating to the development, and validation of drugs, biologics and devices, namely, information in the field of new product development and product testingACTIVENov 7, 2017
044Providing health, medical, pharmaceutical, health management and disease management information to othersACTIVENov 7, 2017
045Regulatory compliance legal research in the field of development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; Regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Providing regulatory information, namely, legal information regarding compliance with pharmaceutical, medical, healthcare, and life sciences regulations; Providing regulatory implementation services, namely, regulatory compliance consulting in the fields of development, validation, and production of drugs, biologics and devices; Providing an online, interactive computer database in the field of regulatory affairs relating to the pharmaceutical, medical, healthcare, and life sciences fieldsACTIVENov 7, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 10, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 10, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 10, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 30, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Oct 2, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 17, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 2, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 27, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 8, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 8, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jun 8, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 8, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 8, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 8, 2018AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Jun 7, 2018IUAAUSE AMENDMENT ACCEPTED—
Jun 6, 2018AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Jun 6, 2018IUAFUSE AMENDMENT FILED—
Jun 5, 2018EAAUTEAS AMENDMENT OF USE RECEIVED—
Mar 7, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 8, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2017DOCKASSIGNED TO EXAMINER—
Sep 12, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 5, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance